St. Louis, Missouri
United States
4
2015-04-16
4
2019-10-22
These are the the leading inventors for applications assigned to BioSynthema Inc.:
BioSynthema Inc. based in St. Louis, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#2 | 2009-12-24 ✅ Patent 8,293,873 granted on 2012-10-23Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take
#3 | 2007-04-10 ✅ Patent 7,202,330 granted on 2007-04-10RGD (Arg-Gly-Asp) coupled to (neuro)peptides
#4 | 2005-09-01 ✅ Patent 7,015,306 granted on 2006-03-21Labeled neurotensin derivatives
Also check out BIOSYNTHEMA INC.'s (St. Louis, United States) applicant profile with 1 patent applications submitted.
90899 ⎘